SYSTEMIC TREATMENT WITH MESOTHELIN-TARGETED ONCOLYTIC ADENOVIRUS SHOWS EFFICACY PATIENT-DERIVED XENOGRAFT OF PANCREATIC CANCER

被引：0
|
作者：
Sato-Dahlman, Mizuho
Miura, Yoshiaki
Hajeri, Praveensingh
Yoshida, Hideki
Jacobsen, Kari
Yanagiba, Chikako
Yamamoto, Masato
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1312
引用
收藏
页码：S517 / S517
页数：1
相关论文
共 50 条
  • [1] Systemic treatment with mesothelin-targeted oncolytic adenovirus shows efficacy patient-derived xenograft of pancreatic cancer
    Sato-Dahlman, Mizuho
    Miura, Yoshiaki
    Hajeri, Praveensingh
    Yoshida, Hideki
    Jacobsen, Kari
    Yanagiba, Chikako
    Yamamoto, Masato
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [2] Efficient Systemic Treatment with Mesothelin-Targeted Oncolytic Adenovirus in Patient-Derived Xenograft (PDX) Model of Pancreatic Cancer
    Sato-Dahlman, Mizuho
    Miura, Yoshiaki
    Hajeri, Praveensingh
    Yoshida, Hideki
    Jacobsen, Kari
    Yanagiba, Chikako
    Yamamoto, Masato
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 330 - 330
  • [3] Efficient Systemic Treatment With Mesothelin-Targeted Oncolytic Adenovirus in Patient- Derived Xenograft (PDX) Model of Pancreatic Cancer
    Sato-Dahlman, M.
    Hajeri, P.
    Yoshida, H.
    Jacobsen, K.
    Yanagiba, C.
    Yamamoto, M.
    [J]. PANCREAS, 2018, 47 (10) : 1421 - 1421
  • [4] Efficacy of Systemic Administration of Mesothelin-Targeted Oncolytic Adenovirus In Pancreatic Cancer
    Sato-Dahlman, Mizuho
    Hajeri, Praveensingh
    Jacobsen, Kari
    Yanagiba, Chikako
    Yamamoto, Masato
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 322 - 323
  • [5] Efficacy of Systemic Administration of Mesothelin-Targeted Oncolytic Adenovirus in Pancreatic Cancer
    Sato-Dahlman, M.
    Hajeri, P.
    Jacobsen, K.
    Yanagiba, C.
    Yamamoto, M.
    [J]. PANCREAS, 2021, 50 (07) : 1095 - 1095
  • [6] EFFICIENT SYSTEMIC TREATMENT WITH MESOTHELIN-TARGETED ONCOLYTIC ADENOVIRUS IN PANCREATIC CANCER
    Sato-Dahlman, Mizuko
    Jacobsen, Kati
    Yanagiba, Chikako
    Yamamoto, Masato
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S469 - S469
  • [7] Intravenous Application of Mesothelin-targeted Oncolytic Adenovirus in Pancreatic Cancer
    Sato-Dahlman, M.
    Miura, Y.
    Hajeri, P.
    Yoshida, H.
    Jacobsen, K.
    Yanagiba, C.
    Yamamoto, M.
    [J]. PANCREAS, 2019, 48 (10) : 1516 - 1516
  • [8] Intravenous Application of Mesothelin-Targeted Oncolytic Adenovirus to Pancreatic Cancer
    Sato-Dahlman, Mizuho
    Miura, Yoshiaki
    Hajeri, Praveensingh
    Yoshida, Hideki
    Jacobsen, Kari
    Yanagiba, Chikako
    Yamamoto, Masato
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 124 - 124
  • [9] Mesothelin-Targeted Infectivity Selective Oncolytic Adenovirus for Pancreatic Cancer by Redesigning the AB-loop via Adenovirus Library Screening
    Miura, Yoshiaki
    Davydova, Julia
    Yamamoto, Masato
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S329 - S329
  • [10] Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin
    Rajeshkumar, N. V.
    Yabuuchi, Shinichi
    Pai, Shweta G.
    De Oliveira, Elizabeth
    Kamphorst, Jurre J.
    Rabinowitz, Joshua D.
    Tejero, Hector
    Al-Shahrour, Fatima
    Hidalgo, Manuel
    Maitra, Anirban
    Dang, Chi V.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (18) : 5639 - 5647
12345